REFERENCES
- Editorial: The treatment of malignant diseases with cytostatic agents. German M. Monthly 1:153–154 (May) 1956.
- Domack, G.: Histological changes in experimental and human malignant tumours after treatment with cytostatic agents. German M. Monthly 1:133–137 (May) 1956.
- Reinhardt, K.: Warburg's theory of carcinogenesis: A review. German M. Monthly 1:152–153 (May) 1956.
- Wolf, H. J. and Gerlich, N.: The use of ethyleneiminoquinone in the treatment of human cancer. German M. Monthly 1:137–138 (May) 1956.
- Progress Report 9. Sloan-Kettering Institute for Cancer Research, June 1956.
- Cannan, R. K.: Caneer research and the Committee on Growth, 1945–1956. National Academy of Sciences, National Research Council News Report, vol. 6 (July-August) 1956.
REFERENCES
- Young, F. G.: Hypoglycaemic and antidiabetic sulphonamides. Brit. M. J. 2:431–432 (August 25) 1956.
- Duncan, L. J. P., Baird, J. D. and Dunlop, D. M.: A clinical trial of BZ 55. Brit. M. J. 2:433–439 (August 25) 1956.
- Wolff, F. W., Stewart, G. A., Crowley, M. F. and Bloom, A.: Trial of an oral hypoglycaemic agent in diabetes. Brit. M. J. 2:440–445 (August 25) 1956.
- Hunt, J. A., Oakley, W. and Lawrence, R. D.: Clinical trial of the new oral hypoglycaemic agent BZ 55. Brit. M. J. 2:445–448 (August 25) 1956.
- McKenzie, J. M., Marshall, P. B., Stowers, J. M. and Hunter, R. B.: BZ 55 in diabetes. Brit. M. J. 2:448–451 (August 25) 1956.
- Walker, G., Leese, W. L. B. and Nabarro, J. D. N.: Hypoglycaemic sulphonamides in treatment of diabetes. Brit. M. J. 2:451–452 (August 25) 1956.
- Murray, I. and Wang, I.: The value of BZ 55 in control of diabetes. Brit. M. J. 2:452–454 (August 25) 1956.
- Editorial: Hypoglycaemic sulphonamides. Brit. M. J. 2:465–467 (August 25) 1956.
REFERENCES
- Ferguson, R. S.: The doctor-patient relationship and “functional” illness. Practitioner 176:636–662 (June) 1956.